While, to our knowledge, this technology has yet to be tested in glioblastoma, Kang et al. demonstrated the successful use of short hairpin RNA (shRNA) to knock down the IL-6 gene in CD19-CAR T-cells. This evidence concerns the gene IL6 and glioblastoma.